Objective: Obesity is widely accepted to be influenced by both environmental and genetic factors. Several recent studies have used the positional cloning approach in an attempt to discover genes contributing to obesity. In the IRAS Family Study a genomewide scan was performed on 1425 individuals of Hispanic descent (90 extended pedigree families) to identify regions of the genome linked to obesity phenotypes. Methods: Nonparametric QTL linkage analysis was performed using a variance components approach. The genome scan was performed in two phases: an initial genome scan in 45 families and a replication scan in 45 families. Fine mapping and candidate gene analyses were also performed. General estimating equations (GEE1) and quantitative pedigree disequilibrium tests (QPDT) were used for association analysis of single SNP and haplotype data. Results: Evidence for linkage to obesity traits was observed in each scan on the long arm of chromosome 17. When data from both scans was combined, a region on chromosome 17q was identified with evidence of linkage to visceral adipose tissue (VAT; LOD 3.11), waist circumference (WAIST) (LOD 2.5) and body mass index (BMI) (LOD 2.81). Nine additional microsatellite markers were identified and genotyped on all Hispanic individuals, with a mean marker density of approximately 1 marker/3 cM. Evidence of linkage remained significant with LOD 3.05 for VAT, LOD 2.44 for BMI and LOD 1.92 for WAIST. Fine mapping analyses suggest the possibility of two different obesity loci. In addition, the LOD -1 interval of the major VAT peak decreased from 83-108 to 95-111 cM. Three positional candidate genes under the peak: somatostatin receptor 2 (SSTR2), galanin receptor 2 (GALR2), and growth hormone bound protein receptor 2 (GRB2) were chosen for detailed evaluation. Multiple polymorphisms within each candidate were genotyped and tested for association with the obesity phenotypes. Little evidence of association was detected between polymorphisms and obesity traits. Conclusion: In conclusion, replication of linkage and fine mapping suggest that a region on chromosome 17q contains a gene (or genes) that contributes to the genetic etiology of obesity with the strongest evidence for linkage to VAT. Candidate genes in the region do not appear to account for the evidence of linkage. Additional studies are necessary to identify the obesity-related polymorphisms.
Introduction
Obesity is a complex disorder caused by multiple genetic and environmental interactions. The prevalence of obesity is steadily increasing worldwide with recent evidence suggesting that over 65 percent of US adults are either overweight or obese (body mass index (BMI)425 kg/m 2 ).
1,2 Moreover, total health care cost, including treatment and obesity management, is estimated at over 75 billion dollars for obesity-related illnesses. 2 Although the environmental changes in the industrial world (i.e. food intake, sedentary lifestyles, etc) are often blamed for the overall increase in this epidemic, an individual's genetic susceptibility is also a major contributory factor. [3] [4] [5] [6] Heritability values of BMI are estimated between 25 and 53%, depending on the population examined. [7] [8] [9] The amount of fat in specific fat depots is also heritable with visceral (VAT) and subcutaneous adipose tissue (SAT) heritability estimates being 50-55% and 40%, respectively. 9 Moreover, the lambda coefficient (l r ), which is the ratio of the risk of being obese when a biological parent is obese compared to the risk of the general population, is estimated to be two to three times higher for an individual with a family history of obesity 10, 11 and five to eight times higher for a severely obese individual. 12 To address the genetic influence of obesity, several large-scale studies have used positional cloning and candidate gene analyses to investigate the genetic etiology of the disease. Multiple regions of the genome have been linked to obesity-related traits and evidence has been reported for association of many individual genes with obesity phenotypes. 13 Possibly reflecting the ethnic and socioeconomic diversity of subjects evaluated in these studies, there has been little replication of chromosomal regions in linkage studies and few confirmations of associations observed with candidate genes. A major aim of the IRAS Family Study is to identify chromosomal regions and specific candidate genes associated with obesity-related traits in two ethnically diverse cohorts: Hispanic and African American. Recent studies have noted that visceral adipose tissue may be more detrimental to one's health than overall obesity. 14, 15 Strengths of the IRASFS include phenotypic data for VAT and SAT, independent of overall obesity, and the ability to carry out replication studies in a large population with uniform phenotypic measures. The IRAFS subjects have been evaluated in detail for measures of obesity and glucose homeostasis. Heritability analyses on six primary obesity phenotypes (BMI, waist circumference (WAIST), waist-hip ratio, VAT, SAT, and visceral-subcutaneous ratio) (VSR) have resulted in heritability estimates ranging from 0.38 to 0.72, with BMI having the highest heritability estimate. 16 In an initial genomewide scan of 1049 subjects from 54 African-American and Hispanic families evidence for linkage of obesity traits was observed with a region on chromosome 6q (African Americans only) and chromosome 12q and 17q (Hispanic cohort only). 16 Here, we report the results of additional genetic mapping on 17q in a replication set of 45 additional Hispanic families, a combined analysis of all Hispanic mapping data, followed by fine mapping in the combined collection of families, and analysis of candidate genes in the linked region.
Research design and methods

Subjects and phenotypes
The IRASFS is a multicenter study designed to investigate the genetic components of insulin resistance and adiposity in a multiethnic population. For the analyses reported here, Hispanic individuals were recruited over a 2.5-year period (2000-2002) from two sites; San Luis Valley, CO, a rural Hispanic population, and San Antonio, TX, an urban Hispanic population. An African-American population from Los Angeles, CA was also recruited but is not the focus of this study. The study design, recruitment, and phenotyping are described in detail. 17 Briefly, 90 multigenerational
Hispanic families (1425 individuals) have been recruited to participate in this component of the study. These families were split into two sets for the genotyping at the Mammalian Genotyping Service (Marshfield, WI, USA) and are referred to as Set 1 (45 total families; 33 families from SA and 12 from SLV; 828 individuals) and Set 2 (27 families from SA and 12 from SLV; 592 individuals). Genome scan results from Set 1 families have been the subject of an earlier report. 16 For this report, genome scan analyses were initially computed separately for the two independent sets of families and then combined for an analysis of all families together. Family size ranged from 4 to 39 individuals. The recruitment was to identify families with at least four living full siblings and five living offspring across the four siblings. Recruitment was independent of diabetes or obesity disease status, however, 13.7% of the individuals self-reported a diagnosis of type 2 diabetes. Informed consent was obtained from all subjects.
Measurement of obesity phenotypes
Several conventional measures of adiposity were obtained in the IRASFS, including body mass index (BMI, kg/m 2 ), waisthip ratio (WHR), and (WAIST; cm). Body mass index was obtained from height and weight measurements at the time of the clinic visit. Similarly, WHR was computed for each individual by measuring WAIST (minimum, between tenth rib and the iliac crest) and hip circumference hip (maximum circumference of the buttocks) at the time of the clinic visit and computing the ratio. In addition to these anthropometric adiposity measurements, a computed tomography (CT) evaluation was performed to estimate visceral and subcutaneous fat (cm 2 ). The procedure consisted of a single scout of the abdomen followed by two 10 mm thick axial images. Axial images were obtained at the L2-L3 and L4-L5 disc spaces, using a standard protocol. Computed tomography images were transferred to magnetic tape and sent to a centralized CT reading center at the University of Colorado Health Sciences Center for analysis. The phenotypes of VAT, SAT, and the ratio between the two (visceral: subcutaneous ratio) were computed from these data. Obesity phenotypes are available from 705 to 737 of the 828 individuals genotyped from MGS1 and 509-531 of the 592 individuals Obesity linkage on chromosome 17 BS Sutton et al genotyped from MGS2. Sample sizes vary due to missing values for some subjects.
DNA preparation and genotyping
Total genomic DNA was purified from whole blood samples obtained from IRASFS subjects using PUREGENE s DNA isolation kits (Gentra Inc., Minneapolis, MN, USA). DNA was quantitated using standardized fluorometric readings on a Hoefer DyNA s Quant s 200 fluorometer (Hoefer Pharmacia Biotech Inc., San Francisco, CA, USA). Any sample with yield o100 mg of DNA was considered inadequate and an additional blood sample was collected from the subject. Each sample was diluted to final concentration of 15 ng/ml. A genome scan consisting of 383 markers at approximately 9 cM intervals was performed by National Heart, Lung and Blood Institute (NHLBI) Mammalian Genotyping Service (MGS, Marshfield, WI, USA). Detailed analyses describing methods of genome scan is described elsewhere. 16 Microsatellite marker genotyping for fine mapping Genotyping of the microsatellite markers were performed using capillary electrophoresis. The PCR reaction was prepared using the Beckman Coulter Biomeck FX Laboratory Workstation (Beckman Instruments, Fullerton, CA, USA). The PCR amplification was performed using 40 ng of genomic DNA in a 14 ml reaction (71 mM KCl, 14 mM TrisHCl pH 8.3, 2.2 mM MgCl 2, 0.14 mM of each dNTP, 0.21 mM of unlabeled oligonucleotide, 0.21 mM of fluorescent -labeled oligonucleotide, and 1.0 unit of Taq polymerase). The PCR reaction was denatured for 2 min at 951C, and then cycled for 30 cycles (45 s at 941C, 45 s at 571C, and 1 min at 721C). The PCR products were then pooled, diluted 1:15 with dH 2 O, and mixed with the internal standard Genescan 500 Rox. The products were run on the ABI PRISM 3700 DNA Analyzer, and the results were analyzed with Genescan Analysis Software. Samples were imported into GeneMapper Software for binning, with each genotype visually inspected and verified. Fifty quality control individuals were placed randomly throughout the plates and checked for accuracy.
Single-nucleotide polymorphism genotyping
Genotypes for the polymorphisms in the three positional candidates (somatostatin receptor 2 (SSTR2), galanin receptor 2 (GALR2), and growth hormone receptor binding protein 2 (GRB2)) were determined using a MassARRAY single-nucleotide polymorphism (SNP) genotyping system (Sequenom Inc., San Diego, CA, USA). This genotyping system uses single base extension reactions to create allele specific products of SNPs that are readily separated and automatically read in a MALDI-TOF mass spectrometer. Primers for PCR amplification and subsequent extension reactions are designed using SpectroDESIGNER assay design software (Sequenom Inc.) and synthesized by Integrated DNA Technology (Santa Clara, CA, USA). The PCR conditions and extensive protocol design is described elsewhere. 18 
Statistical analyses
Map order and genetic distance for each of the markers were taken from the Marshfield genetic map. Maximum likelihood estimates of allele frequencies were computed using the computer program LOKI. 19, 20 Marker data were analyzed using PEDCHECK 21 to identify any Mendelian inconsistencies. Thirty-two individuals had a total of 39 genotypes converted to missing plus six individuals were removed from further analyses due to Mendelian inconsistencies not resolvable via the genome scan data. Quantitative traits were transformed to best approximate the distributional assumptions of the variance component QTL linkage analysis (i.e., conditional normality after adjusting for covariates, homogeneity of variance). Thus, the results reported represent analyses on the square root of VAT and SAT and the natural logarithm of BMI, WHR, and VSR after adding one. Waist circumference was not transformed. All available genotypic data were used to compute the identity by descent (IBD) statistics, using the Bayesian Markov Chain Monte Carlo approach implemented in the software LOKI. 19, 20 Testing for evidence of linkage to a QTL was performed using the variance component approach implemented in the SOLAR software package. 22 The QTL linkage analyses were computed for the entire collection of self-reported Hispanic pedigrees within the IRAS Family Study. Except where noted, all analyses were performed adjusting for age, gender, and recruiting center (San Antonio and San Luis Valley, CO, USA). Although all obesity traits were transformed as necessary to best approximate the conditional multivariate normality and homogeneity of variance assumptions of the variance component model, all LOD scores reported herein are empirical LOD scores determined within SOLAR by simulation (lodadj procedure); the lodadj procedure performs gene dropping simulations to compute a LOD score correction factor.
Positional candidate genes
Single-nucleotide polymorphisms from all three genes were selected from the dbSNP database to comprehensively cover the genomic region containing the positional candidate genes. Those SNPs with available frequency information were preferentially selected from the database. The majority of the SNPs in this study had a minor allele frequency greater than 0.15. Each pedigree was examined for consistency of stated family structure and is described in detail elsewhere. 23 Maximum likelihood estimates of allele frequencies were computed using the largest set of unrelated individuals and tested for departures from Hardy-Weinberg equilibrium proportions. Each of the SNPs evaluated in this work were examined for Mendelian inconsistencies in their genotypes using PEDCHECK. 21 A total of 18 individuals had one genotype converted to missing and five individuals were zeroed for all genotypes due to inconsistency with Mendelian inheritance; the estimated error rate was 0.002%.
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To test for associations among SNP polymorphisms and each trait, a series of generalized estimating equations (GEE1) 24 was computed. The correlation between subjects within a pedigree was adjusted for in the analyses by assuming exchangeable correlation among siblings within a pedigree and computing the sandwich estimator of the variance. 25 The sandwich estimator is also denoted the robust or empirical estimator of the variance and is robust to misspecification of the correlation matrix because it estimates the within pedigree correlation matrix from the first and second moments of the data. For each phenotype and each SNP, the two degree of freedom overall test of genotypic association was performed. Tests reported here were computed adjusting for age, gender, and recruitment center (Los Angeles, CA, USA; San Antonio, TX, USA; and San Luis Valley, CO, USA) and the same transformation for all obesity phenotypes were used as described above. Statistical significance was evaluated by simulation. Specifically, for each SNP and each trait, the gene-dropping algorithm implemented in Mendel 26 was used and the analysis repeated. The empiric P-value is the proportion of time that the simulated data had a P-value smaller than or equal to the observed P-value from the real data. This approach allows the retention of the original correlation among pedigree members in the phenotypic and genotypic data. Empirical P-values are reported in this manuscript. Haplotype analyses were carried out using the quantitative pedigree disequilibrium tests (QPDT), using one, two, three, and four marker moving windows to assess haplotype association. 27 The QPDT uses the expectation-maximization algorithm to estimate the haplotype frequencies and is generally robust to potential population stratification.
Results
Mapping of chromosome 17 obesity loci in replica populations Table 1 lists the primary obesity-related phenotypes measured on study participants and the mean values separately for each set of families and for the combined set. Initially, a genomewide scan was performed on Set 1 Hispanic families to identify regions linked to obesity-related traits. Results from these analyses were reported by Norris et al. 16 and are summarized here: Nonparametric QTL linkage analyses of the Set 1 genotyping data resulted in nominal evidence of linkage to VAT, BMI, and WAIST with LOD scores of 1.62, 1.81, and 1.54, respectively, at 87-94 cM on chromosome 17 (Table 2A) . A second genome scan using individuals from a second set of 45 Hispanic families, Set 2, was performed and data analyzed separately (manuscript in preparation). Analyses of Set 2 data for chromosome 17 also revealed nominal LOD scores of 1.67, 1.24 and 0.76 for these same traits (VAT, BMI, and WAIST), although the linkage evidence maximized slightly distal to 99-101 cM (Table 2A) . Mapping data for chromosome 17 from Set 1 and Set 2 were subsequently combined and analyzed together. When the two sets of families were combined, significant evidence of linkage was observed in the region spanning 92-99 cM with LOD scores of 3.11 (VAT), 2.81 (BMI) and 2.5 (WAIST) (Table 2A) . Interestingly, the maximum LOD scores for VAT and BMI and WAIST appear offset ( Figure 1 ). There was little or no evidence of linkage to SAT, WHR, or VSR in either set or combined (data not shown). With the inclusion of fine mapping markers in the linkage analyses, the magnitude of the LOD score was reduced slightly in all groups but more focused in location. LOD scores for Set 1 linkage analysis for VAT, BMI, and WAIST were 1.27 (103 cM), 0.81 (103 cM), and 0.82 (102 cM), respectively (Table 2B) . LOD scores for Set 2 linkage analysis for VAT, BMI, and WAIST were 1.2 (102 cM), 0.99 (103 cM), and 0.73 (103 cM), respectively. Combining Set 1 and Set 2 in (Figure 2 ). However, after adjusting for BMI, evidence of linkage to VAT and WAIST completely disappeared at the specified location (maximum LOD ¼ 0.35 at 52 cM for VAT). With the introduction of additional markers in the fine mapping, an apparent second peak with evidence of linkage to WAIST with a LOD of 1.89 and BMI with a LOD of 1.78 was observed at 88-91 cM distal to the VAT peak.
Fine mapping analyses
(Evidence of linkage to VAT at 88 cM was nominal with a LOD score of 0.99). Evidence for this second peak is driven by data from Set 1, with LOD scores of 1.34 (87 cM) for BMI, 1.12 (88 cM) for WAIST and 0.9 for VAT, with little evidence of contribution from Set 2 (LODs 0.41 and 0.48 for BMI and WAIST respectively). Similar to the distal peak, no evidence of linkage was detected when WAIST was adjusted for BMI in the linkage analysis (maximum LOD ¼ 0.17 at 114 cM).
Positional candidate analysis
Three positional candidate genes in the LOD-1 interval: galanin receptor 2 (GALR2), growth hormone bound receptor 2 (GRB2), and somatostatin receptor 2 (SSTR2) were chosen to be evaluated for association to obesity phenotypes. The LOD-1 interval for the major VAT peak is located between 96 and 107 cM, corresponding to approximately 68-73 Mb. Approximately, 103 genes are located in this interval. Table 3 lists all SNPs genotyped for each of the three positional candidate genes chosen, the interSNP distance between neighboring SNPs and the minor allele frequency. Little evidence of association to obesity traits was observed with any of the SSTR2 single SNP association GEE1 analyses (Table 4) . Single SNP and haplotype analyses using QPDT were broadly consistent with the single SNP analyses, with the exception that WHR exhibited evidence of association with SNPs G-3477, A-1790G, and A1242G individually and via haplotype analyses (P-values ranging from 0.008 to 0.04).
GRB2 is located at 100 cM, corresponding to genomic position 70.8 Mb. For GRB2, eight polymorphisms were genotyped, spaced fairly evenly throughout the gene. The estimated LD among these SNPs was very high (D 0 40.97 and R 2 X0.70). All GRB2 SNPs showed significant evidence of association (or trending toward association) to VSR, P-values 0.02-0.07 (Table 4) . No additional evidence of association was identified with any other obesity trait, e.g. VAT and BMI. Haplotypic QPDT analysis was consistent with the GEE1 analysis (data not shown): single SNPs were associated (or trending toward association) with VSR (P-values 0.01-0.09) and there was no additional evidence of association for the GRB2 SNPs and other obesity traits using QPDT.
Galanin receptor 2 is located at 102 cM, corresponding to genomic position 71.6 Mb. For GALR2, six polymorphisms were genotyped and spaced throughout the gene to give modest coverage of the entire gene. Using SNPs with allele frequencies 40.10 all SNPs were in high LD (D 0 40.96; r 2 40.60). No association was detected with any polymorphisms for obesity traits using the GEE1 analysis. QPDT analysis was consistent with GEE1, although all SNPs were found to be associated with WAIST after adjustment for BMI. Single SNP and haplotypic associations ranged from 0.01 to 0.07 (data not shown).
Discussion
The IRAS Family Study has measured several obesity phenotypes, including visceral and subcutaneous fat by a CT scan of the abdomen. Only two additional studies have conducted linkage analyses for such sophisticated measurements of adiposity, one in a French Caucasian population and one in an African-American and Caucasian population, 28, 29 To our knowledge, no linkage studies in Hispanic populations have been carried out using CT measures of obesity. Thus, the IRASFS contributes novel data on linkage for specific fat depots in a Hispanic cohort.
In the genome scan incorporating data from 90 Hispanic families, the most significant region of linkage in these Although there are some discrepancies in the genetic maps, one other study has reported suggestive linkage (LODX2.2) to abdominal subcutaneous fat to the same region using single point analysis in a French-Caucasian population. 29 Linkage was identified with markers D17S2180 (67cM), D17S1290 (82cM), and D17S1301 (100 cM), all with a LOD ¼ 2.2. 29 D17S1290 and D17S1301 were also genotyped in the IRASFS, with LOD scores for VAT ¼ 0.53 and 2.84, respectively, and LOD scores for BMI ¼ 1.01 and 2.11, respectively. As the study goal in the French-Caucasian mapping study was to identify regions of the genome linked specifically to abdominal fat depositions, the linkage signal reported was adjusted for total body fat. In addition, evidence for linkage was observed on chromosome 17q23-25 at marker D17S944 (83 cM) to BMI in a separate Caucasian sib-pair population. 30 Although this marker was not genotyped in our IRASFS population, markers D17S1290 (82 cM) and D17S794 (84 cM) were genotyped with LODs for VAT ¼ 0.53 and 0.72, respectively, and LODs for BMI ¼ 1.01 and 1.32, respectively. Individuals from this second Caucasian sib-pair study were selected based on both the proband and one sibling who were severely obese (BMIX35), with 84% if the families possessing a sibling that was considered morbidly obese (BMIX40). Initial linkage analysis showed linkage to BMI with a LOD ¼ 3.0. Subsequent fine mapping analysis increased the LOD score to 3.16 and decreased the LOD-1 interval by 4 cM. Although the region identified in the severe obesity scan is located proximal to the linkage peak identified in our Hispanics, overlap between the studies are evident as the region lies in the LOD-1 interval of the BMI and Waist IRASFS linkage peak, which was linked at both 102 cM and at 92 cM. With evidence of linkage to 17q in the IRASFS Hispanics, fine mapping analysis was performed, with 10 additional markers genotyped on all Hispanic individuals. Evidence of linkage remained significant with all three traits (LOD 1.92-3.06); suggesting one or multiple genes in the region could be contributing to the linkage. To further support the notion of multiple genes in the region, a second, lower magnitude, linkage signal was observed approximately 10 cM upstream from the primary linkage signal at 102 cM. This region was identified only with WAIST and BMI, with LOD 1.9 and 1.8, respectively. Given the large distance between the two peaks (approximately 10 cM), it seems likely that separate genes are contributing the observed linkage to obesity.
These results suggest that VAT, BMI, and WAIST are linked to the 17q region. It is important to note that all three obesity traits have a high degree of correlation in the IRASFS (rX0.70; 31 ). Linkage results reported here are adjusted for age, gender, and center, but not BMI. Interestingly, when data was additionally adjusted for BMI, the evidence for linkage was reduced, thus suggesting that the region harbors a gene or genes contributing to overall obesity and not in specific fat compartment deposition. Further supporting this notion, BMI and waist were linked to the same region as VAT, consistent with this being a general obesity susceptibility locus. Thus, further analysis of this complex region should consider the hypothesis that this region may include both overall obesity and fat depot QTLs. Three genes (SSTR2, GALR2, and GRB2) located under the primary linkage peak at 100 cM were chosen for association analysis with obesity traits. Each of the genes was chosen based on their plausible functional role in obesity or obesityrelated phenotypes. Galanin receptor 2 is a G-protein couple receptor found primarily in the small intestine and various regions of the brain. 32 Galanin binding decreases insulin and somatostatin secretion, stimulates growth hormone-releasing hormones, and has a causative role in obesity by increasing appetite and altering fat metabolism. A second gene, GRB2, is suggested to have a role in the inhibition of fat cell differentiation and to be involved in the leptin signaling pathway. 33 Expression of GRB2 protein in obese insulin-resistant diabetic KKAy mice was dramatically decreased compared to nondiabetic mice. 34 A third positional candidate is SSTR2, a G protein-coupled receptor, inhibits the action of gastrointestinal hormones, specifically gastrin and gastric acid, and reduces the rate of nutrient absorption. 35 Moreover, SSTR2 inhibits the release of insulin, glucagon, and growth hormone secretion. Studies in food deprived rats show an 80% decrease in expression of SSTR2 in the pituitary compared to that of fed rats, suggesting SSTR2 expression may play a role in the feeding mechanisms of rats. 36 There is, however, little evidence of association with any of the genes that would contribute to the linkage evidence in the region. Somatostatin receptor 2 provided the greatest evidence for association, but weak in comparison to the linkage signal. Only one SNP was mildly associated with the linked traits (A1242G P-value 0.05 for WAIST) in single SNP analyses. Haplotype analysis was comparable in magnitude. Interestingly, every SNP genotyped in GRB2 was associated with VSR but not with any other obesity trait, further underscoring the complexity of the region. Additional evaluation of GRB2 and VSR is underway. No association with GALR2 was detected with any obesity phenotypes.
Although we cannot completely exclude these genes from contributions to the evidence of linkage, we found no evidence to support such a contribution. As all SNPs were in fairly high LD within their respective genes, (D 0 X0.7 for all SNPs), it is likely that if one of the genes were associated with obesity, one or more of the genotyped SNPs would have shown association, regardless of whether a functional Obesity linkage on chromosome 17 BS Sutton et al polymorphism was genotyped. In an effort to reveal the true functional variant(s) and gene(s) involved, a high-density 17q SNP map association analysis of the linked region is being performed in this Hispanic sample.
Although positional candidate genes in the proximal, more modest linkage peak on chromosome 17q at 92 cM have not been actively pursued in this study, it is important to note that several good candidates are located in this region. The gene growth hormone 1 (GH1), expressed in the pituitary, encodes a protein involved in growth control. Alterations in this gene could result is different levels of expression of growth hormone. In addition, Johannsson et al. 37 showed that treatment of obese individuals with GH1 can reduce overall VAT and improve insulin sensitivity. Another gene in this region is angiotensin 1 converting enzyme (ACE), which is a potent vasopressor involved in controlling blood pressure and fluid-electrolyte balance. Single-nucleotide polymorphisms in this gene have been found to influence weight gain in three black populations. 38 Evidence of association has been observed with the ACE insertion/deletion polymorphism in relation to obesity in a Chinese population. 39 Finally, another gene of interest in this region is protein kinase, cAMP-dependent, regulatory, type I, alpha (PRKAR1A). The protein encoded by this gene is an important signaling molecule in the cAMP-protein kinase pathway, which further signals the phosphorylation of several downstream targets. A transgenic mouse with a missense gene for PRKAR1A developed adrenocortical hyperplasia, hypercorticosteronemia, and late onset weight gain, in particular in the visceral adipose depot. 40 In conclusion, significant evidence of linkage to obesity phenotypes has been identified in large Hispanic family cohort. Linkage evidence was replicated in two independent Hispanic genome scans and was supported further when the results were combined. Fine mapping analysis suggests the possibility of two distinct regions of chromosome 17 that may harbor genes associated with obesity phenotypes. No evidence was observed that polymorphisms in SSTR2, GRB2, and GALR2 genes contribute to the linkage.
